REFERENCE
Chu E, Schulman KL, Zelt S, Song X.Costs associated with complications are lower with capecitabine than with 5-fluorouracil in patients with colorectal cancer. Cancer 115: 1412-1423, No. 7, 1 Apr 2009
Rights and permissions
About this article
Cite this article
Capecitabine cuts complication costs in colorectal cancer. Pharmacoecon. Outcomes News 578, 4 (2009). https://doi.org/10.2165/00151234-200905780-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905780-00006